[PAR] [TLE] Boots UK [SEP] Boots UK (formerly Boots the Chemists Ltd.), trading as Boots, is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories.  The company's former parent, The Boots Company Plc, merged with Alliance UniChem in 2006 to form Alliance Boots.  In 2007, Alliance Boots was bought by Kohlberg Kravis Roberts and Stefano Pessina, taking the company private, and moving its headquarters to Switzerland, the first ever FTSE 100 company bought by a private equity firm.  In 2012, Walgreens bought a 45% stake in Alliance Boots, with the option to buy the rest within three years.  It exercised this option in 2014, and as a result Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014. [PAR] [TLE] Flosequinan [SEP] Flosequinan is a quinolone vasodilator that was discovered and developed by Boots UK and was sold for about a year under the trade name Manoplax.  It had been approved in 1992 in the US and UK to treat people with heart failure who could not tolerate ACE inhibitors or digitalis.
[PAR] [TLE] Boots UK [ SEP ] Boots UK ( formerly Boots the Chemists Ltd. ) , trading as Boots , is a pharmacy chain in the United Kingdom , Ireland , Norway , Thailand and other territories . The company 's former parent , The Boots Company Plc , merged with Alliance UniChem in 2006 to form Alliance Boots . In 2007 , Alliance Boots was bought by Kohlberg Kravis Roberts and Stefano Pessina , taking the company private , and moving its headquarters to Switzerland , the first ever FTSE 100 company bought by a private equity firm . In 2012 , Walgreens bought a 45 % stake in Alliance Boots , with the option to buy the rest within three years . It exercised this option in 2014 , and as a result Boots became a subsidiary of the new company , Walgreens Boots Alliance , on 31 December 2014 . [PAR] [TLE] Flosequinan [ SEP ] Flosequinan is a quinolone vasodilator that was discovered and developed by Boots UK and was sold for about a year under the trade name Manoplax . It had been approved in 1992 in the US and UK to treat people with heart failure who could not tolerate ACE inhibitors or digitalis .
What was the former parent company of the pharmacy chain that discovered and developed Flosequinan?
What was the former parent company of the pharmacy chain that discovered and developed Flosequinan ?
The Boots Company Plc
The Boots Company Plc